Extended Durability in Exudative Retinal Diseases Using the Novel Intravitreal Anti-VEGF Antibody Biopolymer Conjugate KSI-301 (Year 1 Results of Phase 1b Study in Patients with wAMD, DME and RVO)
By
1200 Page Mill Road Palo Alto, CA 94304 United States of America